Molecular modification of a recombinant, bivalent anti-human CD3 immunotoxin (Bic3) results in reduced in vivo toxicity in mice.

Source:http://linkedlifedata.com/resource/pubmed/id/15661270

Download in:

View as

General Info

PMID
15661270